JP Morgan Downgrades Bioventus to Underweight
JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.
Societe Generale Downgrades AbbVie to Hold
Societe Generale analyst Justin Smith downgrades AbbVie (NYSE:ABBV) from Buy to Hold.
Wolfe Research Downgrades JELD-WEN Holding to Underperform, Announces $7 Price Target
Wolfe Research analyst Truman Patterson downgrades JELD-WEN Holding (NYSE:JELD) from Peer Perform to Underperform and announces $7 price target.
Atlantic Equities Downgrades Marsh & McLennan to Neutral, Announces $185 Price Target
Atlantic Equities analyst John Heagerty downgrades Marsh & McLennan (NYSE:MMC) from Overweight to Neutral and announces $185 price target.
BMO Capital Downgrades Thinkific Labs to Market Perform, Lowers Price Target to C$2
BMO Capital analyst Thanos Moschopoulos downgrades Thinkific Labs (TSX:THNC) from Outperform to Market Perform and lowers the price target from C$3 to C$2.
Deutsche Bank Downgrades Jack In The Box to Hold, Announces $88 Price Target
Deutsche Bank analyst Brian Mullen downgrades Jack In The Box (NASDAQ:JACK) from Buy to Hold and announces $88 price target.
BMO Capital Downgrades National Storage to Market Perform, Lowers Price Target to $42
BMO Capital analyst John Kim downgrades National Storage (NYSE:NSA) from Outperform to Market Perform and lowers the price target from $48 to $42.
Keybanc Downgrades Benefitfocus to Sector Weight
Keybanc analyst Scott Schoenhaus downgrades Benefitfocus (NASDAQ:BNFT) from Overweight to Sector Weight.
RBC Capital Downgrades Q2 Holdings to Sector Perform, Lowers Price Target to $32
RBC Capital analyst Daniel Perlin downgrades Q2 Holdings (NYSE:QTWO) from Outperform to Sector Perform and lowers the price target from $38 to $32.